The growth of some myxoviruses in organ cultures.

PubWeight™: 2.05‹?› | Rank: Top 2%

🔗 View Article (PMC 2094613)

Published in Br J Exp Pathol on October 01, 1965

Authors

D A Tyrrell, B Hoorn

Articles cited by this

A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther (1959) 16.61

Studies on the mechanism of the Shwartzman phenomenon; certain factors involved in the production of the local hemorrhagic necrosis. J Exp Med (1951) 10.51

Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature (1961) 6.74

MECHANISM OF PLATELET PLUG FORMATION AND ROLE OF ADENOSINE DIPHOSPHATE. Am J Physiol (1964) 2.86

Rheomacrodex--a new dextran solution for rheological treatment of impaired capillary flow. Acta Chir Scand (1961) 2.67

Inoculation of human volunteers with parainfluenza viruses types 1 and 3 (HA 2 and HA 1). Br Med J (1959) 2.35

Effects of bacterial endotoxin on rabbit platelets. I. Platelet aggregation and release of platelet factors in vitro. J Exp Med (1961) 2.17

The chemical measurement of histamine in blood plasma and cells. J Pharmacol Exp Ther (1954) 1.57

Effect of adenosine diphosphate on the concentration of platelets in circulating blood. Nature (1963) 1.51

The ultrastructure of rabbit blood platelet aggregates. Thromb Diath Haemorrh (1962) 1.48

The release of histamine from rabbit platelets by means of antigen-antibody precipitates. II. The role of plasma in the release of histamine. J Immunol (1961) 1.40

Indications for the use of low viscous dextran in surgery. Acta Chir Scand (1961) 1.38

COATING OF VASCULAR SURFACES AND CELLS. A NEW CONCEPT IN PREVENTION OF INTRAVASCULAR THROMBOSIS. Proc Soc Exp Biol Med (1964) 1.37

INDUCTION OF VISCOUS METAMORPHOSIS IN HUMAN BLOOD PLATELETS BY MEANS OTHER THAN BY THROMBIN. Nature (1963) 1.31

Relationship of some blood clotting factors to serotonin release from washed platelets. J Appl Physiol (1955) 1.27

Studies on thrombin-induced platelet agglutination. J Exp Med (1961) 1.22

THE MECHANISM AND PREVENTION OF PLATELET ADHESION AND AGGREGATION CONSIDERED IN RELATION TO ARTERIAL THROMBOSIS. Blood (1964) 1.21

Platelet and fibrinogen sequestration. Blood (1960) 1.16

ULTRASTRUCTURAL STUDY OF PLATELET CHANGES INITIATED IN VIVO BY THROMBIN. J Ultrastruct Res (1964) 1.07

Further studies on release of serotonin and histamine during anaphylaxis in the rabbit. Proc Soc Exp Biol Med (1957) 1.01

The reaction between dextrans and the properdincomplement system. I. Inhibition by excess dextran. J Immunol (1960) 0.90

Articles by these authors

Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 9.26

Psychological stress and susceptibility to the common cold. N Engl J Med (1991) 6.84

A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66

Experimental parvoviral infection in humans. J Infect Dis (1985) 4.62

Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31

Trials of Live Influenza Vaccine in the Royal Air Force. Br Med J (1962) 4.06

Inhibition of haemaggregation by lepromin and other mycobacterial substances. Nature (1967) 3.84

Work of a district ethical committee. Br Med J (1979) 3.64

The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect (1990) 3.12

The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10

Inhibition of respiratory virus infection by locally applied interferon. Lancet (1973) 3.02

Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01

Role of viruses in febrile convulsions. Arch Dis Child (1979) 2.72

Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70

Investigetion into the attenuation of influenza viruses by serial passage. Br Med J (1968) 2.67

Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers. Lancet (1975) 2.61

Antiviral activity in milk of possible clinical importance. Lancet (1976) 2.47

Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond) (1967) 2.42

Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2-Hong Kong-68 (H 3 N 2 ) influenza vaccines. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines. J Hyg (Lond) (1972) 2.40

A new virus cultivated only in organ cultures of human ciliated epithelium. Arch Gesamte Virusforsch (1966) 2.34

Common colds on Tristan da Cunha. J Hyg (Lond) (1971) 2.34

New aspects of liposomes. Biochim Biophys Acta (1976) 2.27

A virus from epidemic vomiting disease. Br Med J (1972) 2.26

Organ cultures in virology. Prog Med Virol (1969) 2.21

Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol (1980) 2.21

Improvements in a method of growing respiratory viruses in organ cultures. Br J Exp Pathol (1967) 2.13

Some improved techniques for the study of rhinoviruses using HeLa cells. Arch Gesamte Virusforsch (1968) 2.13

Coronaviridae: second report. Intervirology (1978) 2.05

Cultivation of viruses from a high proportion of patients with colds. Lancet (1966) 2.04

Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines. J Hyg (Lond) (1969) 2.02

Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol (1993) 1.99

Effects of a "new" human respiratory virus in volunteers. Br Med J (1967) 1.98

Trial of ascorbic acid in prevention of colds. Br Med J (1967) 1.90

A year's experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child (1979) 1.85

Experiments on the spread of colds. II. Studies in volunteers with coxsackievirus A21. J Hyg (Lond) (1965) 1.82

A comparative study of attenuated influenza viruses. Bull World Health Organ (1971) 1.81

An investigation of media for the long term storage of three respiratory viruses. Arch Gesamte Virusforsch (1974) 1.78

Toxicity of interferon. Br Med J (Clin Res Ed) (1981) 1.69

The activity of enviroxime against rhinovirus infection in man. Lancet (1981) 1.66

Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli. Lancet (1982) 1.66

Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines. J Hyg (Lond) (1977) 1.62

Further trials of live influenza vaccine. Br Med J (1966) 1.58

The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. J Gen Virol (1967) 1.58

Cultivation of "difficult" viruses from patients with common colds. Br Med J (1968) 1.57

Electron microscopic observations on the entry of influenza virus into susceptible cells. J Gen Virol (1974) 1.55

Coronaviridae. Intervirology (1975) 1.55

Growth of viruses in organ cultures of intestine. Br J Exp Pathol (1970) 1.54

A mathematical model of common-cold epidemics on Tristan da Cunha. J Hyg (Lond) (1971) 1.47

Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand (1979) 1.45

Smoking, alcohol consumption, and susceptibility to the common cold. Am J Public Health (1993) 1.43

Sendai virus infection of rats as a convenient model of acute respiratory infection. Vet Rec (1970) 1.42

The radiation dosimetry of 99Tcm-exametazime. Nucl Med Commun (1990) 1.39

Live influenza vaccines. Lancet (1983) 1.39

Prophylaxis of influenza with a synthetic isoquinoline. Lancet (1968) 1.38

Picornaviridae. Intervirology (1974) 1.36

Failure of oral 4',6-dichloroflavan to protect against rhinovirus infection in man. Arch Virol (1983) 1.35

Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837). Antimicrob Agents Chemother (1989) 1.33

Antibody responses to and efficacy of an inactivated spray vaccine. Bull World Health Organ (1969) 1.29

Deficient production of leucocyte interferon (interferon-alpha) in vitro and in vivo in children with recurrent respiratory tract infections. Lancet (1981) 1.27

Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother (1987) 1.27

Titration of tuberculin, nucleic acids and viruses by haemaggregation inhibition using a "pattern" test. Br J Exp Pathol (1967) 1.26

An epidemic of influenza on Tristan da Cunha. J Hyg (Lond) (1973) 1.26

Identification of rhinovirus stran D.C. Nature (1968) 1.24

Upper respiratory tract viral infection and mucociliary clearance. Eur J Respir Dis (1987) 1.23

Skin tests with influenza virus. J Hyg (Lond) (1973) 1.22

Viruses in febrile convulsions. Lancet (1980) 1.22

Possible virus in schizophrenia and some neurological disorders. Lancet (1979) 1.21

Purified interferon as protection against rhinovirus infection. Br Med J (Clin Res Ed) (1982) 1.21

Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J Gen Virol (2001) 1.19

Epidemic nephropathy in Scandinavia is related to Korean haemorrhagic fever. Lancet (1979) 1.19

Echovirus encephalitis and myositis in primary immunoglobulin deficiency. Arch Dis Child (1978) 1.18

Drug resistant rhinoviruses from the nose of experimentally treated volunteers. Arch Virol (1989) 1.18

Interferon: therapeutic fact or fiction for the '80s? Br Med J (1980) 1.18

Arthritis after meningococcal meningitis. Br Med J (1977) 1.16

A cytotoxic factor in cholera toxin. Br J Exp Pathol (1970) 1.16

Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med (1986) 1.16

Studies on the antiviral activity of 1-adamantanamine. Br J Exp Pathol (1965) 1.16

Some inhibitors of the effect of cholera toxin on HeLa cells. Exp Mol Pathol (1973) 1.12

Prophylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory disease. Thorax (1991) 1.11

A 'new' generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactions. Antiviral Res (1987) 1.09

The propagation of "coronaviruses" in tissue-culture. Arch Gesamte Virusforsch (1969) 1.08

Vaccination against Hong Kong influenza in Britain, 1968-9. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines. J Hyg (Lond) (1970) 1.08

A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity. J Hyg (Lond) (1983) 1.07

Infection and interferon production in systemic juvenile chronic arthritis: a prospective study. Ann Rheum Dis (1984) 1.07

Studies of experimental rhinovirus type 2 infections in polar isolation and in England. J Hyg (Lond) (1976) 1.07

A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity. J Hyg (Lond) (1983) 1.06

Characteristics of patients with schizophrenia or neurological disorder and virus-like agent in cerebrospinal fluid. Lancet (1979) 1.06

Human diploid cell strain rabies vaccine. Rapid prophylactic immunisation of volunteers with small doses. Lancet (1976) 1.04

Inactivation of influenza virus by human lymphocytes. Clin Exp Immunol (1974) 1.04

Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19). J Clin Invest (1987) 1.03

Therapeutic activity of enviroxime against rhinovirus infection in volunteers. Antimicrob Agents Chemother (1983) 1.03

The isolation and partial characterisation of a cytomegalovirus from the brown rat, Rattus norvegicus. Arch Virol (1982) 1.03

Failure of intranasally administered 4', 6-dichloroflavan to protect against rhinovirus infection in man. Arch Virol (1987) 1.03

The possible value of certain cells for the propagation of respiratory viruses. Arch Gesamte Virusforsch (1970) 1.02

Immunity to challenge in volunteers vaccinated with an inactivated current or earlier strain of influenza A(H3N2). J Hyg (Lond) (1978) 1.01

Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteers. Antimicrob Agents Chemother (1985) 1.01